GENERALIZED PUSTULAR PSORIASIS
Clinical trials for GENERALIZED PUSTULAR PSORIASIS explained in plain language.
Never miss a new study
Get alerted when new GENERALIZED PUSTULAR PSORIASIS trials appear
Sign up with your email to follow new studies for GENERALIZED PUSTULAR PSORIASIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug aims to calm dangerous psoriasis outbreaks fast
Disease control Recruiting nowThis study tests an experimental drug called TQH2929 for people with a rare and severe form of psoriasis called generalized pustular psoriasis (GPP) during a sudden flare-up. The trial involves 36 adults who will receive either the drug or a placebo injection. The main goal is to…
Matched conditions: GENERALIZED PUSTULAR PSORIASIS
Phase: PHASE2 • Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. • Aim: Disease control
Last updated May 14, 2026 12:02 UTC
-
New registry tracks GPP to unlock secrets of rare skin disease
Knowledge-focused Recruiting nowThis study is a registry that will follow about 200 people with generalized pustular psoriasis (GPP) across North America. Researchers want to learn more about how GPP develops, how doctors manage it, and what happens to patients over time. The goal is to gather information, not …
Matched conditions: GENERALIZED PUSTULAR PSORIASIS
Sponsor: CorEvitas • Aim: Knowledge-focused
Last updated May 13, 2026 16:03 UTC